Healthcare NSE: SUNPHARMA
Sun Pharmaceutical Shareholding Pattern: Promoter & FII Holding
Sun Pharmaceutical (SUNPHARMA) — Drug Manufacturers - Specialty & Generic
₹1,951.00 INR
▲ ₹11.00 (+0.57%)
Sun Pharmaceutical Shareholding Pattern & Capital Structure
Promoter Holding 55.61%
FII / Institutional Holding 31.02%
Total Cash Reserves ₹33516.58 Cr
Debt-to-Equity Ratio 5.517
Ownership Distribution & Institutional Interest for Sun Pharmaceutical
The ownership structure of Sun Pharmaceutical reflects strong promoter confidence, with promoters holding 55.61% of total outstanding shares. Foreign Institutional Investors (FII) and domestic financial institutions hold 31.02%.
From a balance sheet perspective, Sun Pharmaceutical maintains total cash reserves of ₹33516.58 Cr and a debt-to-equity leverage ratio of 5.517, demonstrating prudential financial risk management.
Frequently Asked Questions
What is promoter holding percentage in Sun Pharmaceutical?
Promoters hold 55.61% of total equity shares in Sun Pharmaceutical.
What is FII and institutional holding in Sun Pharmaceutical?
Foreign Institutional Investors (FII) and domestic institutions hold 31.02% of Sun Pharmaceutical.
What is Sun Pharmaceutical Debt-to-Equity ratio?
Sun Pharmaceutical maintains a debt-to-equity ratio of 5.517, reflecting balance sheet leverage.
How much cash reserves does Sun Pharmaceutical hold?
Sun Pharmaceutical holds total cash and equivalent liquid reserves of ₹33516.58 Cr.
Explore Similar Healthcare Stocks
Explore Categories: